Impact of Size of the Tumour, Persistence of Estrogen Receptors, Progesterone Receptors, HER2Neu Receptors and Ki67 Values on Positivity of Axillary Lymph Nodes in Patients with Early Breast Cancer with Clinically Negative Axillary Examination
- PMID: 29362604
- PMCID: PMC5771280
- DOI: 10.3889/oamjms.2017.213
Impact of Size of the Tumour, Persistence of Estrogen Receptors, Progesterone Receptors, HER2Neu Receptors and Ki67 Values on Positivity of Axillary Lymph Nodes in Patients with Early Breast Cancer with Clinically Negative Axillary Examination
Abstract
Aim: The study aimed to identify factors that influence the positivity of axillary lymph nodes in patients with early breast cancer and clinically negative axillary lymph nodes, who were subjected for modified radical mastectomy and axillary lymphadenectomy.
Material and methods: This study included 81 surgically treated, early breast cancer patients during the period from 08-2015 to 05-2017. All the cases have been analysed by standard histological analysis including macroscopic and microscopic examination by routine H&E staining. For determination of molecular receptors, immunostaining by PT LINK immunoperoxidase has been done for HER2neu, ER, PR, p53 and Ki67.
Results: Patients age ranged between 31-73 years, an average of 56.86 years. The mean size of a primary tumour in the surgically treated patient was 20.33 ± 6.0 mm. Axillary dissection revealed from 5 to 32 lymph nodes, with an average of 14. Metastases have been found in 1 to 7 lymph nodes, with an average 0.7. Only 26 (32.1%) of the patients showed metastases in the axillary lymph nodes. The univariant regression analysis showed that the size of a tumour and presence of HER2neu receptors on cancer cells influence the positivity of the axillary lymph nodes. The presence of the estrogen receptors, progesterone receptors have no influence on the positivity for metastatic deposits of lymph nodes. Multivariant model and logistic regression analysis as significant independent factors or predictors of positivity of the axillary lymph nodes are influenced by the tumour size only.
Conclusion: Our study showed that the metastatic involvement of the axillary lymph nodes is mainly influenced by the size of a tumour and presence of HER2neu receptors in the univariant analysis. This point to the important influence of positivity of the axillary lymph nodes but, in multi-variant regressive analysis the lymph node status correlates with the tumour size only.
Keywords: Ki67; early breast cancer; factors that predict axillary status; lymphovascular invasion; tumour size.
Similar articles
-
Prognostic Factors on the Positivity for Metastases of the Axillary Lymph Nodes from Primary Breast Cancer.Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2017 Mar 1;38(1):81-90. doi: 10.1515/prilozi-2017-0011. Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2017. PMID: 28593885
-
Ki67 index in breast cancer: correlation with other prognostic markers and potential in pakistani patients.Asian Pac J Cancer Prev. 2013;14(7):4353-8. doi: 10.7314/apjcp.2013.14.7.4353. Asian Pac J Cancer Prev. 2013. PMID: 23992002
-
[A new perspective on axillary dissection in situations of metastatic sentinel node].Rozhl Chir. 2017 Fall;96(8):346-352. Rozhl Chir. 2017. PMID: 29058925 Czech.
-
Staging of women with breast cancer after introduction of sentinel node guided axillary dissection.Dan Med J. 2012 Jul;59(7):B4475. Dan Med J. 2012. PMID: 22759850 Review.
-
Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.J Surg Oncol. 2004 Mar;85(3):102-11. doi: 10.1002/jso.20022. J Surg Oncol. 2004. PMID: 14991881 Review.
Cited by
-
Factors Influencing Lymph Node Positivity in HER2/neu+ Breast Cancer Patients.Curr Oncol. 2023 Feb 27;30(3):2825-2833. doi: 10.3390/curroncol30030215. Curr Oncol. 2023. PMID: 36975428 Free PMC article.
References
-
- Carter CL, Allen C, Henson DE. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer. 1989;63:181–187. https://doi.org/10.1002/1097-0142(19890101)63:1<181::AID-CNCR28206301.... - PubMed
-
- Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Annals of Surgery. 1994;220(3):391–401. https://doi.org/10.1097/00000658-199409000-00015 PMid:8092905 PMCid:PMC1234400. - PMC - PubMed
-
- Maunsell E, Brisson J, &Deshenes L. Arm problems and psychological distress after surgery for breast cancer. Canadian Journal of Surgery. 1993;36:315–320. PMid:8370012. - PubMed
-
- Fisher B, Jeong JH, Anderson S, et al. Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy and total mastectomy followed by irradiation. N Engl J Med. 2002;347(8):567–575. https://doi.org/10.1056/NEJMoa020128 PMid:12192016. - PubMed
-
- Veronesi U, Saccozzi R, Del Vecchio M, et al. Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancer of the breast. N Engl J Med. 1981;305(1):6–11. https://doi.org/10.1056/NEJM198107023050102 PMid:7015141. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous